U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2023
455
Name Type Language
NIRSEVIMAB
INN   USAN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN F0 (PROTEIN F))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-456) (HUMAN VH (HOMO SAPIENS IGHV1-69*01(IGHD)-IGHJ4*01 (90.1%)) (8.8.19) (1-126) -HOMO SAPIENS IGHG1*03
Systematic Name English
Nirsevimab [WHO-DD]
Common Name English
NIRSEVIMAB [USAN]
Common Name English
NIRSEVIMAB [JAN]
Common Name English
MED-18897
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN)(HUMAN MONOCLONAL MED18897 .GAMMA.1-CHAIN), DISULFIDE WITH MONOCLONAL MED18897 .KAPPA.-CHAIN, DIMER
Systematic Name English
nirsevimab [INN]
Common Name English
MEDI8897
Code English
Code System Code Type Description
USAN
FG-140
Created by admin on Sat Dec 16 13:39:01 GMT 2023 , Edited by admin on Sat Dec 16 13:39:01 GMT 2023
PRIMARY
FDA UNII
VRN8S9CW5V
Created by admin on Sat Dec 16 13:39:01 GMT 2023 , Edited by admin on Sat Dec 16 13:39:01 GMT 2023
PRIMARY
CAS
1989556-22-0
Created by admin on Sat Dec 16 13:39:01 GMT 2023 , Edited by admin on Sat Dec 16 13:39:01 GMT 2023
NO STRUCTURE GIVEN
INN
10780
Created by admin on Sat Dec 16 13:39:01 GMT 2023 , Edited by admin on Sat Dec 16 13:39:01 GMT 2023
PRIMARY
NCI_THESAURUS
C170224
Created by admin on Sat Dec 16 13:39:01 GMT 2023 , Edited by admin on Sat Dec 16 13:39:01 GMT 2023
PRIMARY
ACTIVE MOIETY
NIRSEVIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966